Broad spectrum antiviral agent niclosamide and its therapeutic potential

J Xu, PY Shi, H Li, J Zhou - ACS infectious diseases, 2020 - ACS Publications
The recent outbreak of coronavirus disease 2019 (COVID-19) highlights an urgent need for
therapeutics. Through a series of drug repurposing screening campaigns, niclosamide, an …

Niclosamide for Covid-19: bridging the gap

HM Al-Kuraishy, AI Al-Gareeb, KJ Alzahrani… - Molecular Biology …, 2021 - Springer
Aim/purpose Niclosamide (NCL) is an anthelminthic drug, which is widely used to treat
various diseases due to its pleiotropic anti-inflammatory and antiviral activities. NCL …

Overview of recent strategic advances in medicinal chemistry

G Wu, T Zhao, D Kang, J Zhang, Y Song… - Journal of medicinal …, 2019 - ACS Publications
Introducing novel strategies, concepts, and technologies that speed up drug discovery and
the drug development cycle is of great importance both in the highly competitive …

Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies

MJ Dodge, KM MacNeil, TM Tessier, JB Weinberg… - Antiviral research, 2021 - Elsevier
Human adenoviruses (HAdV) are ubiquitous human pathogens that cause a significant
burden of respiratory, ocular, and gastrointestinal illnesses. Although HAdV infections are …

Oncolytic virotherapy: From bench to bedside

L Yang, X Gu, J Yu, S Ge, X Fan - Frontiers in Cell and …, 2021 - frontiersin.org
Oncolytic viruses are naturally occurring or genetically engineered viruses that can replicate
preferentially in tumor cells and inhibit tumor growth. These viruses have been considered …

Niclosamide encapsulated in mesoporous silica and geopolymer: A potential oral formulation for COVID-19

H Piao, NS Rejinold, G Choi, YR Pei, G Jin… - Microporous and …, 2021 - Elsevier
COVID-19 is a rapidly evolving emergency, for which there have been no specific
medication found yet. Therefore, it is necessary to find a solution for this ongoing pandemic …

Expanding the activity spectrum of antiviral agents

A Ianevski, PI Andersen, A Merits, M Bjørås… - Drug discovery today, 2019 - Elsevier
Highlights•Broad-spectrum antivirals target≥ 3 viral diseases.•108 safe-in-man broad-
spectrum antiviral agents were identified.•These agents could reinforce the arsenal of …

Potential COVID‐19 therapeutic agents and vaccines: an evidence‐based review

E Khani, S Khiali… - The Journal of Clinical …, 2021 - Wiley Online Library
Since the early days of 2020, the severe acute respiratory syndrome coronavirus 2
pandemic has become a global health concern. Currently, some therapies and vaccines …

Therapeutic potential of salicylamide derivatives for combating viral infections

J Xu, Y Xue, AA Bolinger, J Li, M Zhou… - Medicinal Research …, 2023 - Wiley Online Library
Since time immemorial human beings have constantly been fighting against viral infections.
The ongoing and devastating coronavirus disease 2019 pandemic represents one of the …

[HTML][HTML] Niclosamide inhibits hepatitis E virus through suppression of NF-kappaB signalling

Y Li, P Li, Q He, R Zhang, Y Li, N Kamar… - Antiviral Research, 2022 - Elsevier
Hepatitis E virus (HEV) infection can cause severe acute hepatitis in pregnant women and
chronic infection in immunocompromised patients, promoting the development of effective …